N TERMINAL-PRO BRAIN NATRIURETIC PEPTIDE (NT PRO BNP) LEVELS IN CONGESTIVE CARDIAC FAILURE

Abstract

Background- HF according to recent definition is described as a clinical illness characterized 
by signs and/or symptoms brought on by a structural or functional cardiac defect, which was 
supported by objective evidence of systemic or pulmonary congestion or by high levels of 
natriuretic peptide. We aimed to assess the role of N Terminal-Pro Brain Natriuretic Peptide 
(Nt Pro BNP) levels in Congestive Cardiac Failure and controls as well as to assess its 
correlation with age, gender, body mass index, troponin, electrocardiographic and 2D 
echocardiographic abnormalities in patients with CCF